We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPOK:NASDAQSpok Holdings, Inc. Analysis

Data as of 2026-06-03 - not real-time

$10.95

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Spok is trading at $10.95, which sits below its 20‑day SMA of $10.83 and 50‑day SMA of $11.03, with the RSI hovering around 51 and a modest bullish MACD histogram despite an overall bearish trend and decreasing volume. The price is anchored near a support level of $10.41 and faces resistance around $11.13, suggesting limited upside in the immediate term. Technical indicators point to a short‑term consolidation phase while the market sentiment is extremely greedy (Fear & Greed Index 93).
Fundamentally, the company generates $136.6 M in revenue (down 8.5% YoY) but maintains a healthy 60% gross margin and a positive cash flow generation of $19.8 M free cash. Its PE of 18.6 is well below the industry average of 27, and the DCF model values the stock at roughly $13, implying an upside of about 28%. The dividend yield is an eye‑catching 11.4% but the payout ratio exceeds 200%, raising sustainability concerns. With a low beta of 0.41, modest debt ($6.2 M) and strong cash reserves, the stock appears undervalued from a valuation standpoint, though revenue decline and dividend risk temper the outlook. Recent accolades for nine consecutive years as a top‑rated secure messaging provider reinforce its market leadership and could support longer‑term growth.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages indicating limited near‑term upside
  • Decreasing volume and bearish trend direction
  • High dividend yield but unsustainable payout ratio

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value suggests ~28% upside
  • Low beta and strong cash generation support a rebound
  • Market leadership validated by repeated industry awards

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Revenue contraction and dividend sustainability concerns
  • Stable gross margins and recurring subscription model
  • Regulatory exposure in healthcare communications

Key Metrics & Analysis

Financial Health

Revenue Growth-8.50%
Profit Margin9.27%
P/E Ratio18.6
ROE8.66%
ROA5.29%
Debt/Equity4.41
P/B Ratio1.6
Op. Cash Flow$29.1M
Free Cash Flow$19.8M
Industry P/E27.0

Technical Analysis

TrendBearish
RSI51.1
Support$10.41
Resistance$11.13
MA 20$10.83
MA 50$11.03
MA 200$13.61
MACDBullish
VolumeDecreasing
Fear & Greed Index93.27

Valuation

Fair Value$13.00
Target Price$14.00
Upside/Downside27.85%
GradeUndervalued
TypeValue
Dividend Yield11.41%

Risk Assessment

Beta0.41
Volatility25.11%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.